Clinical Pilot and Feasibility Award
Funds clinical research projects using human subjects or samples to explore new hypotheses, methods, or gaps in cystic fibrosis, with a focus on innovation and health disparities.
Funder: Cystic Fibrosis Foundation
Due Dates: April 2, 2026 (Letter of Intent) | August 16, 2026 (Full application) | August 17, 2026 (Full application, alternate date)
Funding Amounts: Up to $80,000/year (+12% indirects) for single-center studies; up to $150,000/year (+12% indirects) for multi-center studies; up to 2 years; additional $50,000 supplement possible.
Summary: Supports innovative clinical research projects involving human subjects or samples to develop and test new hypotheses and methods in cystic fibrosis.
Description
This award funds clinical pilot and feasibility research projects involving human subjects or samples that address new hypotheses, methods, or under-explored questions in cystic fibrosis (CF). The goal is to enable investigators to collect preliminary data to inform larger-scale or multi-center studies. The program encourages both new and established investigators, especially those proposing novel research directions or addressing gaps in CF knowledge. Projects may focus on diagnosis, treatment, management, or the pathophysiology of CF, and special consideration is given to proposals that address health disparities or innovative approaches.
